Clinical Topics

Racial Disparities Found in BRCA Testing, Counseling

by U.S. Medicine

July 22, 2019

DURHAM, NC—Despite increases in BRCA mutation testing, racial/ethnic disparities in counseling and testing have persisted for decades, a study argued.

The review published in the Journal of Racial and Ethnic Health Disparities said its purpose was to summarize recent literature as it relates to detecting, understanding and reducing disparities in BRCA counseling and testing.1

Durham, NC, VAMC researchers and colleagues focused on articles published January 2012 to July 2017 relevant to genetic testing and counseling, breast and ovarian cancer and minority health and heath disparities. Overall, 23 articles were included in the review.

Study authors noted that research has reported lower counseling and/or testing rates for eligible racial/ethnic minorities among family members of high-risk individuals, as well as among breast cancer survivors.

The review found that Key barriers and facilitators of disparate BRCA counseling/testing include:

  • awareness, 
  • cost-related factors, 
  • stress and distrust, 
  • family concerns and communication, and 
  • provider communication and referral.

“To address differential access to and use of BRCA testing services and expand testing in minority populations, it is necessary for interventions to focus on improving awareness, risk-perception, and family and patient-provider communication,” the authors wrote, adding, ‘Multi-level and targeted interventions are needed to reduce persistent racial/ethnic disparities and improve assessment, provider recommendations, counseling and testing among minority populations.’

Williams CD, Bullard AJ, O’Leary M, Thomas R, Redding TS 4th, Goldstein K. Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review. J Racial Ethn Health Disparities. 2019 Jun;6(3):570-583. doi:10.1007/s40615-018-00556-7. Epub 2019 Apr 8. PubMed PMID: 30963508.



Related Articles

Virtual Reality Tested for Phantom Limb Pain in Veteran Amputees

SAN DIEGO—Virtual reality appears to be a feasible way to treat phantom limb pain at the VA, according to a small new study. The report in Pain Medicine sought To describe the development of a... View Article

VA Researcher Helps Develop Promising New Pain Drug

NEW ORLEANS—A new drug with less risk for addiction and overdose compared to currently available opioid medications is showing promise, according to a recently published research article. The drug, developed at Southeast Louisiana Veterans Health... View Article


U.S. Medicine Recommends


More From oncology

Oncology

VA Guideline Addresses Dental Management of Head/Neck Cancer Patients

SAN FRANCISCO—Few protocols have been published for the dental management of patients with head and neck cancer to prevent complications from head and neck radiation therapy, according to a new study.  The report in the... View Article

Oncology

Patients Treated with Thiopurines Have Higher Skin Cancer Mortality

PHILADELPHIA—Treatment with thiopurines is associated with an increased risk of squamous cell carcinoma of the skin in patients with inflammatory bowel diseases. An article in Clinical Gastroenterology and Hepatology discussed results of a study that... View Article

Oncology

Overcoming Radiation Resistant Prostate Cancer

LOS ANGELES—For nearly half of the patients with localized advanced prostate cancer, radiation therapy is the primary intervention and standard of care for recurrent disease following surgery. The problem is that nearly 30% to 50%... View Article

Oncology

JAK Enzymes Can Treat Leukemia, Lymphoma

NASHVILLE, TN—Precision oncology prescribes the use of molecularly-targeted therapy directed by identification of genomic alterations. A new study suggested the approach is particularly applicable to neoplasms that are resistant to standard cytotoxic chemotherapy, such as... View Article

Oncology

Response of Veterans to PD-1 Checkpoint Inhibitors

RENO, NV—The clinical outcomes and the incidence of adverse events for programmed death-1 checkpoint inhibitors in cancer patients at a VA clinic were different from the data that have been published, according to a new... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up